Ram Temple construction dates to be announced this year: Sakshi

Bengaluru, May 17: At least 54 new COVID-19 positive cases have emerged since last evening, raising Karnataka's tally to 1,146, a health official said today.

Among the 1,146 cases, 611 are active and isolated in designated hospitals across the state, 497 patients got discharged and 37 died of the virus.

Of the new cases, Mandya district alone reported 22 cases, followed by 10 in Kalaburgi, 6 in Hassan, 4 in Dharward, 3 each in Kolar and Yadgir, 2 each in Dakshina Kannada and Shivamogga and 1 each in Udupi and Shivamogga.

New Cases Reported: 54
Total Active Cases: 611
Total Discharges: 497
Total Covid Deaths: 37
Death of Covid +ve patient due to Non-Covid cause: 1
Total Positive Cases: 1146

Udupi/Mangaluru, Mar 1: A total of twenty leaplings were born in the hospitals of the Udupi and Dakshina Kannada (DK) districts on Saturday, February 29, district health department said on Sunday.

According to the district health department, sixteen babies were born in DK district while Udupi district saw four births. More boys than girls were born in DK (12–4) and it was the inverse in Udupi district (3–1).

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.